In a report on the cross-sectional data of our population-based cohort, GIP and GLP-1 responses (tAUC) were increased in T2DM patients, but not in persons with intermediate hyperglycaemia[29]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.